Will Canopy Growth Corp (TSX:WEED) Hit $1 Billion in Sales Next Year?

Some are predicting that Canopy Growth Corp (TSX:WEED)(NYSE:CGC) will hit $1 billion in sales for 2019

| More on:
edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Remember the Canopy Growth Corp (TSX:WEED)(NYSE:CGC)/Constellation Brands (NYSE:STZ) acquisition?

Last year, it was one of the biggest stories in the Canadian markets. After months of legalization hype, Constellation announced in August that it would be acquiring a huge $5 billion stake in Canopy, bringing its total ownership to 35%. The acquisition began a massive rally in weed stocks that raised not only Canopy, but also most of its competitors.

Since last fall, the Constellation deal has seen few new developments. But the company’s CEO recently spoke out in a rare public comment that may reveal why Constellation was willing to pay so much in the 2018 deal.

Constellation CEO says Canopy headed to $1 billion in annual revenue

In a recent conference call, Constellation Brands CEO Bill Newlands claimed that Canopy Growth would hit $1 billion in revenue by 2020. This was not the first time that Newlands made this claim. However, it was the first time he was able to back it up with clear data. Using Canopy’s $83 million in Q3 revenue and 282% net revenue growth rate, he concluded that a “run rate” of $1 billion was within striking distance.

Why $1 billion is such a crucial benchmark

You see, $1 billion in revenue is a crucial milestone for Constellation Brands for one simple reason: its stake in Canopy is massive. Not only did it invest $5 billion in Canopy stock last year, but it took a smaller stake a few months prior to that. This is a company with a huge chunk of coin riding on Canada’s largest weed stock. A valuation of $5 billion implies that Canopy will be worth that much from its discounted future cash flows–notwithstanding the possibility of Constellation simply dumping its Canopy shares at a high price.

For Canopy to be worth that much over, say, a 50-year period, it needs to generate $100 million a year in net income for 50 years. Given the typical profit margins in the cannabis space, the company would therefore have to start doing well over a billion in sales to be worth what Constellation paid for it.

Canopy’s revenue growth

It’s definitely within the realm of possibility that Canopy could hit $1 billion in revenue this year or the next. Judging by last quarter’s sales, the company could earn up to $332 million this year. If last quarter’s net revenue growth rate stays steady into next year at 280%, then that $332 million could rise to $929 million next year. That’s just a hair short of a billion.

Also, if Canopy sees accelerating revenue growth this year, it’s not impossible that the company could even hit the $1 billion mark before 2019 is out. However, it would require significant acceleration, as Canopy’s quarter by quarter revenue growth in 2018 was not amazing. In Q2 (which corresponds to Q3 of the 2018 calendar year), for example, revenue was actually down from Q1, at $23 million vs $25 million.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »